new
   What Are the Indications of Ivosidenib (Tibsovo)?
501
Jan 07, 2026

Ivosidenib (Tibsovo) is an important isocitrate dehydrogenase-1 (IDH1) inhibitor, providing an innovative treatment option for patients with various malignant tumors harboring IDH1 mutations.

What Are the Indications of Ivosidenib (Tibsovo)?

Newly Diagnosed Acute Myeloid Leukemia (AML)

Patient Population: Indicated for adult patients with newly diagnosed AML who are 75 years of age or older, or who are ineligible for standard intensive induction chemotherapy due to comorbidities (e.g., severe impairment of cardiac, pulmonary, hepatic, or renal function).

Treatment Regimen: Can be administered as a monotherapy or in combination with azacitidine.

Relapsed or Refractory Acute Myeloid Leukemia (AML)

Patient Population: Indicated for adult patients with AML whose disease has relapsed or is refractory to prior treatment.

Relapsed or Refractory Myelodysplastic Syndromes (MDS)

Patient Population: Indicated for adult patients with MDS whose disease has relapsed or is refractory to prior treatment.

Locally Advanced or Metastatic Cholangiocarcinoma

Patient Population: Indicated for adult patients with locally advanced or metastatic cholangiocarcinoma whose disease has progressed after at least one prior systemic therapy regimen (e.g., regimens containing gemcitabine or 5-fluorouracil).

Dosage Form and Appearance of Ivosidenib (Tibsovo)

Dosage Strength: Each tablet contains 250 mg of active ingredient.

Appearance: The tablets are blue and oval-shaped, engraved with "IVO" on one side and "250" on the other for easy identification.

Packaging: Typically supplied in bottles containing 60 tablets each, with a desiccant canister inside the bottle to maintain drug stability.

Storage and Handling Requirements for Ivosidenib (Tibsovo)

Storage Temperature

Store at controlled room temperature between 20°C and 25°C (68°F and 77°F).

Short-term storage between 15°C and 30°C (59°F and 86°F) is permitted.

Storage Conditions

Keep the medication in its original bottle, and store in a dry place, protected from direct sunlight, moisture, and excessive heat.

Important Notes

The desiccant canister inside the bottle is used for moisture absorption and preservation; do not remove or discard it.

Keep the medication out of the reach and sight of children to ensure safety.

Note: For internal discussion among medical personnel only. For specific medication, please consult the attending physician. Drug information may change over time. For the latest information, we recommend adding a medical consultant or consulting for free online.
Ivosidenib(Tibsovo)
Adult patients with relapsed or refractory acute myeloid leukemia.
RELATED ARTICLES
What Are the Indications of Ivosidenib (Tibsovo)?

Ivosidenib (Tibsovo) is an important isocitrate dehydrogenase-1 (IDH1) inhibitor, providing an innovative treatment...

Wednesday, January 7th, 2026, 11:50
Dosage, Administration and Recommended Dose of Ivosidenib (Tibsovo)

Ivosidenib (Tibsovo) is the first targeted therapy indicated for acute myeloid leukemia (AML) with IDH1 mutations,...

Wednesday, January 7th, 2026, 11:32
Channels for Purchasing Tibsovo® (Ivosidenib)

Tibsovo® (Ivosidenib) is an oral targeted therapy indicated for IDH1 mutations. It has been approved by the U.S....

Wednesday, January 7th, 2026, 11:24
Adverse Reactions of Ivosidenib (Tibsovo)

Ivosidenib (Tibsovo) is an isocitrate dehydrogenase 1 (IDH1) inhibitor, primarily indicated for the treatment of...

Thursday, December 18th, 2025, 11:48
RELATED MEDICATIONS
Enasidenib
Treatment of relapsed or refractory acute myeloid leukemia (AML) in adult...
TOP
1
Glasdegib
DAURISMO is indicated in combination with low-dose cytarabine for the treatment...
TOP
2
Xospata
Treatment of relapsed or refractory acute myeloid leukemia (AML) in adults with...
TOP
3
Tretinoin
VESANOID is indicated for the induction of remission in adults and pediatric...
Gemtuzumab ozogamicin
Gemtuzumab ozogamicin is a CD33-directed antibody and cytotoxic drug conjugate...
Quizartinib
VANFLYTA is indicated for adult patients with newly diagnosed Acute Myeloid...
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
haiousales@gmail.com
Welcome To Consult
Seagull Pharmacy.,Ltd All rights reserved